4//SEC Filing
Komjathy Andrew 4
Accession 0001179110-19-010493
CIK 0001454789other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:29 PM ET
Size
5.5 KB
Accession
0001179110-19-010493
Insider Transaction Report
Form 4
Komjathy Andrew
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2019-09-18+44,500→ 44,500 totalExercise: $5.92Exp: 2029-09-17→ Common Stock (44,500 underlying)
Footnotes (1)
- [F1]This option was granted on September 18, 2019 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of September 18, 2019 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
Documents
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeother
Related Parties
1- filerCIK 0001788465
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:29 PM ET
- Size
- 5.5 KB